openPR Logo
Press release

Monogenetic Disorders testing Market Emerging Trends and Top Key Players to Watch-AutoGenomics, Abbott, ELITechGroup, Quest Diagnostics in 2017-2025

06-03-2019 01:09 PM CET | Health & Medicine

Press release from: Monogenetic Disorders testing Market

Monogenetic Disorders testing Market Emerging Trends and Top

According to Mendel's Laws, the monogenetic disorders are inherited because of a single defective gene on the autosomes. The monogenic disorders are caused by single mutated gene which can be present on single or both chromosomes. Females and males are equally affected by this disorder due to the conditions on the autosomes. Some of the tests are available for the mainstream of the common monogenic disorders such as Cystic fibrosis, sickle cell anemia, SCID, Tay-sachs disease, polycystic kidney disorder, Gaucher's disease, Huntington's disease, neurofibromatosis, thalassaemia and familial hypercholesterolemia. There are several test performed to treat with the monogenic disorders such as diagnostic testing, carrier testing, predictive & pre-symptomatic testing, prenatal testing and new-born screening. The Carrier testing consists a type of genetic testing that is used to determine a carrier person for monogenic disorders. Predictive testing which is also known as pre-symptomatic testing is performed to detect the gene associated mutations with disorders that appear after birth and often later in life. Prenatal testing is performed during the pregnancy to detect the problems that could affect the child. New born screening testing is performed by a simple blood test to detect the certain conditions that can eventually cause problems.

Free Sample Copy of this report @

The global monogenetic disorders testing market is driven by rising awareness of genetic disorders among the population. The advanced technological platforms and improved genomic tools make the monogenetic disorders testing market feasible. The monogenetic disorders testing market is driven by the unique opportunity and the focused issues stress that need for more research on monogenic disorder tests and. Increasing prevalence of monogenic disorders throughout the globe will also boost the growth of the monogenetic disorders testing market. Lack of skilled professionals, and lack of knowledge act as a restraint to the market.

The monogenetic disorders testing market is classified by the test type, disorder type and end user.

Global Monogenetic Disorders Testing Market segmented, by Test Type-

Carrier Testing
Diagnostic Testing
New-born Screening
Predictive & Pre-Symptomatic Testing
Prenatal Testing

Global Monogenetic Disorders Testing Market segmented, by Disorder Type-

Cystic fibrosis
Sickle Cell Anemia
Severe Combined Immunodeficiency (SCID)
Tay-sachs Disorder
Polycystic Kidney Disorder
Gaucher's Disease
Huntington's Disease
Familial Hypercholesterolemia

Global Monogenetic Disorders Testing Market segmented, by End User-

Ambulatory Surgical Centers
Specialized Clinics

The increasing investment by the hospital facilities and government for better healthcare is expected to drive the market. The monogenetic disorders testing market is classified by test type, disorder type and end user. The global monogenic disorder testing market is segmented by test type including carrier testing, diagnostic testing, new-born screening, predictive & pre-symptomatic testing and prenatal testing. In terms of disorder the global monogenetic disorders testing market is segmented into cystic fibrosis, sickle cell anemia, severe combined immunodeficiency (SCID), Tay-sachs disorder, polycystic kidney disorder, gaucher's disease, huntington's disease, neurofibromatosis, thalassaemia and familial hypercholesterolemia. By end user, the global monogenetic disorders testing market is classified into hospitals, specialized clinics and ambulatory surgical centers. Hospitals are expected to gain the maximum value share over the forecast period.

On the basis of geography, the global monogenetic disorders testing market is segmented as North America, Latin America, Europe, Asia-Pacific and Middle East & Africa. North America clearly dominates the global monogenetic disorders testing market due to high degree of intelligence and awareness regarding to the monogenic disorders testing procedures. The companies are focused on introducing the procedures with innovative technology, Europe is expected to hold the second large market followed by Asia-Pacific region.

Some of the key players across the value chain of global monogenetic disorders testing market are Celera Group, Abbott, ELITechGroup, Quest Diagnostics, AutoGenomics, PerkinElmer Inc., Roche Diagnostics, Bio-Rad Laboratories, Inc., Applied Biosystems Inc., and Transgenomic Inc.

MRR.BIZ has been compiled in-depth market research data in the report after exhaustive primary and secondary research. Our team of able, experienced in-house analysts has collated the information through personal interviews and study of industry databases, journals, and reputable paid sources.

The report provides the following information:

Tailwinds and headwinds molding the market’s trajectory
Market segments based on products, technology, and applications
Prospects of each segment
Overall current and possible future size of the market
Growth pace of the market
Competitive landscape and key players’ strategies

The main aim of the report is to:

Enable key stakeholder’s in the market bet right on it
Understand the opportunities and pitfalls awaiting them
Assess the overall growth scope in the near term
Strategize effectively with respect to production and distribution

Request For TOC of Report @

MRR.BIZ is a leading provider of strategic market research. Our vast repository consists research reports, data books, company profiles, and regional market data sheets. We regularly update the data and analysis of a wide-ranging products and services around the world. As readers, you will have access to the latest information on almost 300 industries and their sub-segments. Both large Fortune 500 companies and SMEs have found those useful. This is because we customize our offerings keeping in mind the specific requirements of our clients.

About us is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.


Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Monogenetic Disorders testing Market Emerging Trends and Top Key Players to Watch-AutoGenomics, Abbott, ELITechGroup, Quest Diagnostics in 2017-2025 here

News-ID: 1762398 • Views: 181

More Releases for Disorder

Antidepressant Drugs Market Report 2018: Segmentation by Depressive Disorder (Ma …
Global Antidepressant Drugs market research report provides company profile for Alkermes Plc, Allergan Plc, Bristol Myers Squibb Co., Eli Lilly and Co., GlaxoSmithKline Plc, H. Lundbeck, Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms
Pigmentation Disorder Treatment Market 2017 - 2025
Skin pigmentation refers to a skin disorder that causes either lightening of skin or darkening of skin when compared to the existing skin color. In general, hyperpigmentary disorder relates to darkening of skin and hypopigmentation means lightening of skin color. Pigmentation disorders affect the skin color causing skin appear as discolored and blotchy. Color of skin is regulated by a skin component called melanin which is produced by some special
Somatostatin Receptor Market For Hormonal Disorder, Oncology, Metabolic Disorder
MarketResearchReports.Biz adds “Global Somatostatin Receptor Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Somatostatin Receptor and the growth estimates for the forecasted period. This report studies the Somatostatin Receptor Type 2 market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global
Hyperactivity Disorder Treatment Market - Trends,2025
Attention deficit hyperactivity disorder (ADHD) is a neural disorder. The disorder is characterized by impulsiveness, hyperactivity, and attention difficulty. Treatment of ADHD involves a combination of counseling, medications, and lifestyle changes. ADHD is the most commonly diagnosed mental disorder in adults and children with the exact cause being unidentified in the majority of cases. Researchers at the National Institute of Mental Health (NIMH) suggest the factors affecting mental illness include heredity,
Global Bipolar Disorder Market
The Bipolar Disorder Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Bipolar disorder is also known as manic-depressive illness. Bipolar disorder is a brain disorder that causes unusual shifts in mood and activity levels of an individual. Some researchers and scientists have
Summer Heats Up Eating Disorder Warning Signs
NEW YORK (April 9, 2012) – Swapping freezing temperatures for the triple digits doesn’t just mark the start of summer. For teenage girls burdened by body-image concerns, swimsuit season can awaken eating disorder behaviors that may have hibernated or gone unnoticed during the colder months. Dr. Judy Scheel, Ph.D., author of When Food is Family: A Loving Approach to Heal Eating Disorders, warns parents and caregivers to look for signs